Article metrics

Download PDFPDF

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops et al
Free

 

Online download statistics by month:

Online download statistics by month: June 2020 to August 2020

AbstractFullPdf
Jun 202033733492
Jul 2020369367171
Aug 202013513338
Total841834301